Menstrual symptom questionnaire: further psychometric evaluation

Novak, Jones, and Jones (1975) state that menstrual distress (dysmenorrhea) is the greatest cause of lost work hours among women, and Kistner (1970) estimate this to be 140 million annual work hours. Thirty-five percent of female adolescents. 25% of college women, and 60–70% of single females in their 30's and 40's are said to be invalid during menstruation (Green, 1971). Treatment procedures for primary dysmenorrhea have included hypnosis (Lackie, 1964), physical exercises (Golub. 1959). natural childbirth techniques (House, 1969), and oral contraceptives.

Though hormones are the most recent, frequent and effective treatment approach (Novak et al. 1975). Tyler (1973) cautions against their use because of possible adverse side effects. Recently, systematic desensitization (SD) has been used to relieve menstrual distress (Mullen, 1968, 1971; Reich, 1972; Tasto and Chesney, 1974) without risk of such side effects. Although SD has been effective, considerable response variability has been noted.

Becuase of this variability. Chesney and Tasto (1975a) developed the Menstrual Symptom Questionnaire (MSQ) to psychometrically identify two types of primary dysmenorrhea: spasdomic dysmenorrhea which designates distress during the flow period associated with excessive muscle tension, and congestive dysmenorrhea referring to premenstrual tension related to water retention. This instrument was designed to define types of menstrual symptoms and not symptom severity. Test-retest reliability was 0.87 and discrimination between spasdomic and congestive dysmenorrhea was highly significant. Of 48 women tested. 29 were identified as spasdomic with MSQ scores between 82 and 102, while 19 scored in the congestive range (46–68). Interestingly, no women scored in the median range (69–81), suggesting that there exists two unique types of primary dysmenorrhea identifiable by the MSQ. Subsequently, Chesney and Tasto (1975b) reported that congestive women did not respond to SD, while spasdomic symptoms were significantly reduced. It was hypothesized that the relaxation training component of SD was effective with spasmodic muscle tension symptoms and ineffective with congestive water retention symptoms. Consequently, the MSQ was thought capable of accounting for previously reported response variability of primary dysmenorrhea to SD.

The present study was intended to replicate Chesney and Tasto's (1975a, 1975b) findings. The following Null hypotheses were tested; (a) the MSQ does not have significant test-retest reliability; (b) the congestive-spasmodic symptom dimension of the MSQ is not dichotomous; and (c) the MSQ does not predict SD effectiveness